Yann Cormerais

Biography

Publications

• De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma.

  Teisseire M, Sahu U, Parola J, Tsai MC, Vial V, Durivault J, Grépin R, Cormerais Y, Molina C, Gouraud A, Pagès G, Ben-Sahra I, Giuliano S. Cancer Res 2025 May 15

  PMID: 40029310

• AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth.

  Cormerais Y, Lapp SC, Kalafut KC, Cissé MY, Shin J, Stefadu B, Personnaz J, Schrotter S, D'Amore A, Martin ER, Salussolia CL, Sahin M, Menon S, Byles V, Manning BD. bioRxiv 2024 Sep 23

  PMID: 39386441

• Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin.

  Byles V, Cormerais Y, Kalafut K, Barrera V, Hughes Hallett JE, Sui SH, Asara JM, Adams CM, Hoxhaj G, Ben-Sahra I, Manning BD. Mol Metab 2021 11

  PMID: 34303878

• A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCTKO Pancreatic Ductal Adenocarcinoma Cells.

  Meira W, Daher B, Parks SK, Cormerais Y, Durivault J, Tambutte E, Pouyssegur J, Vucetic M. Cancers (Basel) 2021 Mar 21

  PMID: 33801101

• Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer.

  Cormerais Y, Vucetic M, Parks SK, Pouyssegur J. Int J Mol Sci 2020 Dec 22

  PMID: 33375025